Drug & medication recalls Moderate risk

RETINOIC ACID all strengths including 0 recalled over sterility concerns

Recall date
February 10, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Synergy Rx recalls RETINOIC ACID all strengths including 0.025%, 0.05% and 0.1% CREAM, RETINOIC ACID 0.025%/CLINDAMYCIN 1.2% GEL, RETINOIC…
Recall number
D-0541-2017
FDA classification
Class II
Brand / firm
Synergy Rx
Sold / distributed
Nationwide within the United States

Why it was recalled

Lack of Assurance of Sterility: There are also CGMP Deviations.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

RETINOIC ACID all strengths including 0.025%, 0.05% and 0.1% CREAM, RETINOIC ACID 0.025%/CLINDAMYCIN 1.2% GEL, RETINOIC ACID 0.025%/ HYALURONIC ACID CREAM, RETINOIC ACID 0.05%/HYALURONIC ACID CREAM, RETINOIC ACID 0.1% IN CERAVE CREAM, RETINOIC ACID POWDER 1 GRAM, RETINOIC ACID/HYALURONIC ACID 0.1%/0.1% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

Get recall alerts

Free email alert whenever Synergy Rx has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Synergy Rx